JM, D., GW, S., M, G., & GD, P. (2020). Levetiracetam vs. phenytoin as 2nd-line treatment for status epilepticus: A systematic review and meta-analysis. Epilepsy & behavior : E&B, 111, 107286. https://doi.org/10.1016/j.yebeh.2020.107286
Chicago Style (17th ed.) CitationJM, DeMott, Slocum GW, Gottlieb M, and Peksa GD. "Levetiracetam Vs. Phenytoin as 2nd-line Treatment for Status Epilepticus: A Systematic Review and Meta-analysis." Epilepsy & Behavior : E&B 111 (2020): 107286. https://doi.org/10.1016/j.yebeh.2020.107286.
MLA (9th ed.) CitationJM, DeMott, et al. "Levetiracetam Vs. Phenytoin as 2nd-line Treatment for Status Epilepticus: A Systematic Review and Meta-analysis." Epilepsy & Behavior : E&B, vol. 111, 2020, p. 107286, https://doi.org/10.1016/j.yebeh.2020.107286.